d͏t͏p͏S͏s͏n͏r͏e͏o͏o͏5͏1͏1͏t͏6͏2͏9͏5͏8͏2͏c͏2͏6͏f͏u͏5͏2͏m͏0͏h͏2͏4͏6͏u͏t͏1͏i͏5͏a͏l͏8͏a͏t͏a͏c͏5͏5͏0͏0͏3͏2͏f͏m͏3͏2͏i͏i͏4͏l͏g͏ 
SBRT ~ STEREOTACTIC BODY RADIATION THERAPY
A Complete Clinical & Technical Masterclass
SBRT also called SABR (Stereotactic Ablative Body Radiotherapy
represents one of the major advances in modern radiation oncology.
It is not simply “high-dose radiation in a few fractions.”
SBRT is a complete treatment philosophy built around:
🎯 Precise target definition
📐 High geometric accuracy
💥 Ablative dose per fraction
📉 Rapid dose fall-off
🫁 Motion management
📸 High-quality image guidance
🛡️ Strict OAR constraints
🧪 Robust quality assurance
The goal is simple:
«Deliver an ablative dose to the target while maintaining an acceptable risk of toxicity to surrounding normal tissues.»
AAPM TG-101 established a framework for implementing SBRT programs, including patient immobilization, localization, motion management, treatment planning, delivery, documentation and QA. More recently, AAPM-RSS MPPG 9.b (2025) updated the minimum medical-physics practice expectations for linac-based photon SRS/SBRT services.
—
1️⃣ WHAT EXACTLY IS SBRT?
SBRT is a form of external-beam radiotherapy characterized by highly precise delivery of a relatively high biological dose in a limited number of fractions.
Unlike conventional fractionation, which may involve many treatment sessions, SBRT commonly uses a small number of fractions.
But there is an important point:
There is NO single universal SBRT prescription.
The appropriate dose and fractionation depend on:
• Tumor site
• Tumor size
• Tumor location
• Histology
• OAR proximity
• Motion
• Previous RT
• Clinical intent
• Institutional protocol
• Evidence from the relevant disease site
Therefore, saying:
«“SBRT = 5 fractions”»
is an oversimplification.
—
2️⃣ SBRT vs CONVENTIONAL RT
Conventional RT
Generally:
Lower dose/fraction
→
More fractions
→
Longer treatment course
SBRT
Generally:
Higher dose/fraction
→
Fewer fractions
→
Highly conformal treatment
The fundamental difference is not simply the number of fractions.
It is the combination of:
Dose + Fraction Size + Precision + Target Selection + OAR Protection
—
3️⃣ WHY DOES SBRT WORK?
The biological effect of SBRT is more complex than simply increasing the physical dose.
A high dose per fraction can produce significant:
DNA damage
and can also influence:
Tumor vasculature
Tumor microenvironment
Immune response
Cellular repair mechanisms
This is one reason SBRT is often described as an ablative treatment approach.
However, the clinical effect is strongly dependent on tumor biology and dose distribution.
—
4️⃣ THE RADIOBIOLOGY — BED
One of the most important concepts when discussing SBRT is:
Biologically Effective Dose (BED)
A commonly used model is:
BED = nd [1 + d/(α/β)]
where:
n = number of fractions
d = dose per fraction
α/β = tissue-specific parameter
The important concept is that increasing the dose per fraction can substantially increase BED, especially for tissues with a low α/β ratio.
But there is a major warning:
«BED is a model, not a direct clinical toxicity predictor.»
It should not be used in isolation to compare completely different clinical situations.
—
5️⃣ WHERE IS SBRT USED?
SBRT has become an important treatment modality for selected tumors in multiple anatomical sites.
🫁 LUNG
One of the best-established applications.
SBRT is widely used for appropriately selected patients with early-stage NSCLC, particularly when surgery is not appropriate.
ASTRO’s early-stage NSCLC guideline specifically addresses SBRT in medically inoperable patients and challenging scenarios such as central tumors, large tumors, multifocal disease and salvage treatment.
—
🧠 SPINE
Spinal SBRT can provide:
• High local control
• Pain control
• Ablative treatment of selected spinal metastases
But spinal cord tolerance becomes a major limiting factor.
Therefore:
«The spinal cord can become the prescription-limiting structure.»
—
🧠 LIVER
SBRT can be used for selected:
• Hepatocellular carcinoma
• Cholangiocarcinoma
• Liver metastases
Important considerations include:
Normal liver volume
Liver function
Tumor size
Tumor location
Bowel/stomach proximity
Respiratory motion
—
🫘 ADRENAL
Selected adrenal metastases can be treated with SBRT, particularly in oligometastatic or oligoprogressive disease.
—
🧠 PANCREAS
SBRT is increasingly used in carefully selected pancreatic cancer settings, but pancreatic SBRT is technically challenging because of the close proximity of:
Duodenum
Stomach
Small bowel
and other critical structures.
Here, OAR constraints may strongly influence the prescription.
—
🦴 BONE
SBRT can provide high-dose local treatment for selected spinal and non-spinal metastases.
ASTRO’s bone-metastases guideline conditionally recommends SBRT over conventional palliative RT for selected patients with good performance status who do not require surgery or have neurological symptoms.
—
6️⃣ OLIGOMETASTATIC DISEASE
One of the most interesting developments in SBRT is its role in:
Metastasis-Directed Therapy
The idea is that some patients with limited metastatic disease may benefit from aggressive local treatment of metastatic sites.
But this does not mean:
«“Every patient with metastases should receive SBRT.”»
Patient selection is critical.
Important factors include:
• Number of metastases
• Total metastatic burden
• Disease-free interval
• Primary tumor biology
• Systemic therapy options
• Performance status
• Location of metastases
• Technical feasibility
• OAR constraints
ASTRO/ESTRO guidance for oligometastatic NSCLC recommends definitive local therapy only in carefully selected patients and emphasizes multidisciplinary assessment, appropriate imaging and integration with systemic therapy.
—
7️⃣ THE FIRST MAJOR CHALLENGE:
MOTION
This is where SBRT becomes very different from many conventional treatments.
Consider a lung tumor.
The patient breathes.
The tumor moves.
Therefore:
The tumor is NOT a stationary target.
If we plan treatment on a single static CT image without understanding respiratory motion, we may irradiate the wrong anatomical position.
—
8️⃣ 4DCT
4DCT = Four-Dimensional CT
The fourth dimension is:
TIME
The CT images are correlated with the respiratory cycle.
Instead of seeing:
«“Where is the tumor?”»
we can ask:
«“Where does the tumor move during breathing?”»
4DCT can help characterize:
• Tumor motion
• Tumor trajectory
• Internal motion
• Respiratory phases
• ITV definition
This is one of the fundamental tools in thoracic and upper-abdominal SBRT.
AAPM materials specifically identify 4D imaging and motion management as important components of SBRT practice.
—
9️⃣ ITV — INTERNAL TARGET VOLUME
For a moving target, one approach is to create:
ITV
The ITV encompasses the tumor’s expected motion envelope.
Conceptually:
GTV at different respiratory phases
↓
Motion envelope
↓
ITV
↓
PTV
The exact workflow depends on the motion-management strategy.
—
🔟 MOTION MANAGEMENT STRATEGIES
Several approaches can be used.
1. Free Breathing
The tumor moves naturally.
Motion is characterized and incorporated into the planning strategy.
—
2. Abdominal Compression
Mechanical compression can reduce respiratory excursion in selected patients.
The objective is:
Reduce tumor motion
rather than eliminate breathing.
—
3. Breath Hold
The patient holds their breath at a reproducible respiratory position.
This can reduce internal motion and improve reproducibility.
—
4. Respiratory Gating
Radiation is delivered only during a predefined phase or amplitude of the respiratory cycle.
—
5. Tumor Tracking
The treatment system continuously or repeatedly determines the tumor position and adjusts delivery accordingly.
—
1️⃣1️⃣ TARGET DEFINITION
SBRT demands excellent target delineation.
Typical concepts include:
GTV
Gross visible tumor.
CTV
Potential microscopic disease when clinically appropriate.
ITV
Important when respiratory motion is incorporated into the target definition.
PTV
Accounts for remaining geometric uncertainties.
The exact use of CTV and ITV is site- and protocol-dependent.
There is no universal SBRT margin that should be copied from one anatomical site to another.
—
1️⃣2️⃣ IMAGING FUSION
SBRT planning frequently requires multimodality imaging.
Depending on the tumor:
CT
+
MRI
+
PET/CT
may provide complementary information.
But image registration introduces another source of uncertainty.
Therefore:
Image registration is part of target accuracy.
A small registration error can become clinically important when the treatment margin is very small.
—
1️⃣3️⃣ PTV MARGINS
In conventional RT, relatively larger margins may be used.
SBRT often uses tighter margins because the entire treatment philosophy depends on high geometric accuracy.
But:
«Smaller margin ≠ automatically better treatment.»
If the margin is too small for the actual uncertainties of the department, target miss becomes possible.
The correct margin should reflect:
Setup uncertainty
Imaging accuracy
Intrafraction motion
Immobilization
Mechanical accuracy
Treatment delivery accuracy
—
1️⃣4️⃣ TREATMENT PLANNING
Modern SBRT planning may use:
3D-CRT
IMRT
VMAT
Multiple arcs
Non-coplanar beam arrangements
depending on the site and treatment platform.
The plan should achieve:
High target coverage
+
High conformity
+
Appropriate dose gradient
+
OAR protection
—
1️⃣5️⃣ CONFORMITY
A good SBRT plan attempts to conform the prescription isodose closely around the target.
The goal:
Dose follows tumor geometry.
Not:
Dose follows a large surrounding volume.
This becomes especially important when the tumor is surrounded by radiosensitive tissue.
—
1️⃣6️⃣ DOSE GRADIENT
The dose should fall rapidly outside the target when clinically appropriate.
Conceptually:
Tumor
████████████
Immediately outside target
███
Further away
█
This steep gradient is one of the characteristics that makes SBRT powerful.
But it also makes SBRT unforgiving.
—
1️⃣7️⃣ THE PRICE OF A STEEP GRADIENT
A steep dose gradient is beneficial:
when your geometry is correct.
But dangerous:
when your geometry is wrong.
If the patient shifts several millimeters, the high-dose region may shift relative to the target and OARs.
Therefore:
«Stereotactic accuracy is not optional.»
—
1️⃣8️⃣ OARs — THE REAL LIMITING FACTOR
In many SBRT cases, the tumor does not determine the prescription.
The OAR does.
Depending on the anatomical site, critical structures may include:
Lung
• Spinal cord
• Esophagus
• Heart
• Great vessels
• Trachea
• Main bronchi
Liver
• Stomach
• Duodenum
• Bowel
• Kidneys
• Normal liver
Spine
• Spinal cord
• Cauda equina
• Esophagus
• Bowel
Pancreas
• Duodenum
• Stomach
• Small bowel
• Large bowel
• Kidneys
• Liver
—
1️⃣9️⃣ OAR CONSTRAINTS
This is a critical point:
There is no single universal OAR constraint table for every SBRT case.
Constraints depend on:
Fractionation
Treatment site
Previous radiation
Volume
Contouring methodology
Clinical protocol
Dose calculation
Patient factors
Therefore:
«Never copy an OAR constraint from one SBRT protocol and apply it blindly to another fractionation scheme.»
AAPM TG-101 remains a foundational reference, while modern protocols and disease-site guidelines should also be consulted.
—
2️⃣0️⃣ HETEROGENEITY
SBRT plans can intentionally contain substantial dose heterogeneity inside the target.
The prescription dose does not necessarily mean:
«“Every voxel inside the PTV must receive exactly the prescription.”»
High-dose regions may occur within the target depending on the planning strategy and protocol.
What matters is:
Appropriate target coverage
Clinically acceptable hot spots
Safe dose gradient
OAR protection
This is why evaluating only a single prescription isodose line is not enough.
—
2️⃣1️⃣ DVH — DON’T LOOK AT ONE NUMBER
For SBRT, the DVH is essential.
But a complete plan review should consider:
Target
• D98
• D95
• D50
• D2
• V100
• V95
depending on the protocol.
OARs
• Maximum dose
• Near-maximum dose
• Mean dose
• Volume thresholds
again depending on the organ and protocol.
But remember:
«The DVH tells you how much dose an organ receives — not where it receives it.»
Therefore:
DVH + Isodose Distribution + Anatomy
must be interpreted together.
—
2️⃣2️⃣ DOSE CALCULATION
Small fields and high dose gradients create dosimetric challenges.
The TPS must accurately model:
• Small fields
• MLC transmission
• Penumbra
• Heterogeneity
• Tissue interfaces
• Build-up region
• Lung density effects
For lung SBRT, heterogeneity correction and accurate modeling of low-density lung tissue are particularly important.
—
2️⃣3️⃣ SMALL-FIELD DOSIMETRY
SBRT often uses small apertures.
Small-field dosimetry is challenging because:
• Lateral charged-particle equilibrium may not exist
• Detector volume can become significant relative to field size
• Output factors become sensitive to detector characteristics
• MLC modeling becomes important
Therefore, detector selection and commissioning are critical components of an SBRT program.
—
2️⃣4️⃣ IGRT
Image-Guided Radiation Therapy
is fundamental to SBRT.
Possible technologies include:
CBCT
kV imaging
Surface guidance
Respiratory monitoring
Implanted fiducials in selected cases
Tumor tracking
The exact technology depends on the treatment site and machine.
—
2️⃣5️⃣ SETUP ACCURACY
Imagine a tumor that is only a few centimeters.
Now imagine a high-dose gradient around it.
A setup error of a few millimeters may become clinically relevant.
Therefore:
Patient positioning must be verified immediately before treatment.
And depending on the treatment strategy:
Intrafraction motion must also be monitored.
—
2️⃣6️⃣ RADIATION THERAPIST’S ROLE
The Radiation Therapist is a critical part of SBRT safety.
Before treatment:
✔ Correct patient
✔ Correct site
✔ Correct immobilization
✔ Correct treatment plan
✔ Correct accessories
✔ Correct image-guidance protocol
During treatment:
✔ Verify positioning
✔ Perform image matching
✔ Monitor patient motion
✔ Verify respiratory conditions when required
✔ Maintain communication
✔ Interrupt treatment if safety criteria are not met
After treatment:
✔ Verify delivery
✔ Document treatment
✔ Report relevant events or deviations
In SBRT:
«The Radiation Therapist is not simply operating the LINAC.»
The therapist is one of the final safety barriers between the approved plan and actual patient delivery.
—
2️⃣7️⃣ QUALITY ASSURANCE
SBRT requires a comprehensive QA program.
Machine QA
Mechanical accuracy
↓
Imaging accuracy
↓
Radiation output
↓
MLC performance
↓
Treatment delivery
—
Patient-Specific QA
Depending on institutional practice:
• Dosimetric verification
• Delivery verification
• Independent checks
• Plan review
—
End-to-End QA
The entire chain is tested:
Imaging
→
Planning
→
Localization
→
Treatment delivery
AAPM TG-101 and the newer MPPG 9.b provide important frameworks for SBRT/SRS program implementation and physics support.
—
2️⃣8️⃣ SBRT SAFETY
SBRT is extremely precise.
That means:
The consequences of an error can also be amplified.
Potential failure points include:
• Wrong patient
• Wrong site
• Incorrect contour
• Incorrect image registration
• Incorrect motion model
• Incorrect treatment plan
• Incorrect OAR contour
• Incorrect prescription
• Incorrect setup
• Equipment error
• Failure of image guidance
Therefore:
SBRT needs a culture of safety — not just advanced equipment.
ASTRO maintains a dedicated SRS/SBRT safety white paper addressing safe implementation of these high-precision techniques.
—
2️⃣9️⃣ SBRT TOXICITY
The high dose per fraction can produce excellent tumor control.
But it can also increase the risk of serious toxicity if critical structures receive excessive dose.
Depending on the site, complications can include:
Lung
Radiation pneumonitis
Chest-wall toxicity
Rib fracture
Liver
Radiation-induced liver injury
Spine
Myelopathy
GI
Ulceration
Bleeding
Perforation
Kidney
Renal toxicity
The exact risk depends on:
Dose
Fractionation
Volume
OAR anatomy
Previous RT
Patient factors
—
3️⃣0️⃣ RE-IRRADIATION
One of the most difficult SBRT scenarios is:
SBRT after previous radiotherapy.
Now the team must consider:
Previous dose
+
Previous fractionation
+
Time interval
+
Current dose
+
Overlap volume
+
Cumulative OAR exposure
This is not simply:
«“The previous dose was 60 Gy, so we have 40 Gy left.”»
Radiobiological modeling and dose accumulation are much more complicated.
Recent ESTRO/EORTC consensus work emphasizes that re-irradiation involves concern about cumulative doses and overlapping irradiated volumes, requiring structured assessment rather than simplistic subtraction of physical doses.
—
3️⃣1️⃣ SBRT FOR LUNG — A PRACTICAL EXAMPLE
Consider a patient with an early-stage peripheral NSCLC.
The treatment pathway may look like:
Diagnosis
↓
Staging
↓
PET/CT ± MRI
↓
Multidisciplinary evaluation
↓
CT simulation
↓
4DCT
↓
Motion assessment
↓
GTV contouring
↓
ITV / motion strategy
↓
PTV
↓
IMRT / VMAT planning
↓
OAR optimization
↓
Plan evaluation
↓
QA
↓
Image guidance
↓
SBRT delivery
↓
Follow-up imaging
ASTRO specifically recognizes SBRT as an established option for appropriately selected early-stage NSCLC patients, particularly those who are medically inoperable.
—
3️⃣2️⃣ WHAT MAKES SBRT DIFFERENT FROM “JUST VMAT”?
This is an important distinction.
VMAT is a delivery technique.
SBRT is a treatment strategy.
You can use VMAT to deliver SBRT.
But:
«VMAT ≠ SBRT»
SBRT requires the entire stereotactic framework:
Patient selection
Target definition
Motion management
Small margins
High dose per fraction
High geometric accuracy
IGRT
OAR constraints
QA
—
3️⃣3️⃣ THE SBRT TRIANGLE
Think of SBRT as a balance between three major priorities:
🎯 TARGET
Adequate tumor dose
🛡️ OAR
Normal tissue protection
📐 ACCURACY
Geometric precision
If you sacrifice any one of these:
The treatment may no longer be safe or clinically appropriate.
—
3️⃣4️⃣ THE MOST IMPORTANT QUESTION
When reviewing an SBRT plan, don’t ask only:
«“Does the PTV meet the prescription?”»
Ask:
1. Is the target correctly defined?
2. Is motion properly characterized?
3. Is the margin justified?
4. Is the dose distribution appropriate?
5. Is the gradient clinically acceptable?
6. Are OAR constraints satisfied?
7. Is the plan deliverable?
8. Is the patient position reproducible?
9. Is image guidance adequate?
10. Has the entire treatment chain been verified?
—
🔥 FINAL TAKEAWAY
SBRT is not simply:
“High dose + few fractions.”
It is:
High-dose radiobiology
+
high-precision geometry
+
motion management
+
image guidance
+
advanced treatment planning
+
strict OAR protection
+
comprehensive QA
The technology may be a LINAC.
The technique may be VMAT.
The imaging may be CBCT.
The TPS may generate a beautiful plan.
But none of these alone makes a treatment SBRT.
SBRT is a complete system.
And the ultimate objective is not:
«“Deliver the highest possible dose.”»
It is:
«“Deliver the highest clinically appropriate ablative dose to the target while maintaining an acceptable probability of normal-tissue toxicity.”»
That is the real meaning of stereotactic ablative radiotherapy.
—
☢️ RADIOTHERAPY WORLD ACADEMY